Literature DB >> 10429492

[Secondary glaucoma in Paraguay. Etiology and incidence].

A Strohl1, S Pozzi, R Wattiez, B Roesen, H Miño de Kaspar, V Klauss.   

Abstract

Glaucoma is the third-most-frequent cause of blindness in the world, with a total of 5.2 million blind people as a result of this disease; 80% live in developing countries. In Paraguay, after cataract it is the second-most-frequent-cause. Early detection of the risk factors and groups can help to avoid progress of this disease. Trauma, cataract and infectious uveitis represent special risks for developing secondary glaucoma, which is a more frequent cause of blindness in third-world countries than in industrialized nations. Until now there has been little data regarding the causes, disease course, and options for therapy. Therefore, secondary glaucoma was examined in Paraguay to obtain information on the situation in Latin America. The aim of the study was to explore the causes of secondary glaucoma for programs concerning prevention and therapy. From November 1996 to February 1997 patients with secondary glaucoma were examined at the University Hospital of Asunción, Paraguay. After the clinical examination the secondary glaucomas were classified. Patients with primary glaucoma were included in the same period of time as well in order to get the rate of secondary glaucoma. Altogether 293 patients were examined: 61 with secondary and 232 with primary glaucoma. The causes of secondary glaucoma in 73 eyes were: 20 (27%) with pseudoexfoliation glaucoma, 19 (26%) with post-traumatic glaucoma, 16 (22%) with neovascular glaucoma, 4 (5%) with lens-related glaucoma, 3 (4%) with glaucoma associated with ocular surgery, 2 (3%) with pigmentary and 2 (3%) with corticoid-induced glaucoma. A ratio of 4:1 primary glaucomas to secondary glaucomas was found. The development of special measures for prevention and early therapy is only possible if the causes of this severe disease are explored. The results of this study represent basic information and could help to introduce of prevention programs.

Entities:  

Mesh:

Year:  1999        PMID: 10429492     DOI: 10.1007/s003470050418

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  2 in total

1.  [Neovascular glaucoma: aetiology, pathogenesis and treatment].

Authors:  K U Löffler
Journal:  Ophthalmologe       Date:  2006-12       Impact factor: 1.059

2.  Presentation of glaucoma in an urban tertiary care hospital in South America: legal blindness and prevalence.

Authors:  Tammy Hentona Osaki; Niro Kasahara; Mauricio Della Paolera; Ralph Cohen; Maria Cristina Nishiwaki-Dantas
Journal:  Int Ophthalmol       Date:  2010-02-25       Impact factor: 2.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.